跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Razine
Approved
STANDARD
Razine
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3b4445d42acbf3e8
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
3b4445d42acbf3e8
Drug Approval Philippines Name
Razine
Product Name
Razine
Registration Number
DR-XY37422
Brand Name
Razine
Generic Name
Ranolazine
Dosage Form
Extended-Release Tablet
Dosage Strength
500mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines, Inc.
Distributor
Ajanta Pharma Philippines, Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
29 November 2024
Expiry Date
01 February 2030
Pharmacologic Category
Anti-angina
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3b4445d42acbf3e8
Type
Standard
Back to Philippines FDA Approvals
Razine - Philippines FDA Drug Approval Details